References
- . Cohen C, Evans AA, London WT, Block J, Conti M, Block T. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat. 2008;15(1):12–13
- . Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–662
- . Hann HW, Han SH, Block TM, . Symptomatology and health attitudes of chronic hepatitis B patients in the USA. J Viral Hepat. 2008;15(1):42–51
- . Tran TT. Understanding cultural barriers in hepatitis B virus infection. Cleve Clin J Med. 2009;76( suppl 3):S10–S13
- . Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004–2006. Adv Data. 2008;394:1–22
- . Spiegel BM, Bolus R, Han S, . Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0. Hepatology. 2007;46(1):113–121
- . Tsang T. Asian American Pacific Islander National Health Summit, September 14–16, 2006. http://liver.stanford.edu/Public/presentations/AAPIhealthsummit-NewYork-ThomasTsang.pps. Accessed January 10, 2010
- . Synovate Healthcare. Hepatitis B Monitor Q1 2009, Syndicated Research Study. Philadelphia, PA; 2009
- . Keeffe EB, Dieterich DT, Han SH, . A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4(8):936–962
- . Chen CJ, Iloeje UH, Yang HI. Long-term outcomes in hepatitis B: the REVEAL-HBV study. Clin Liver Dis. 2007;11(4):797–816
- . Straley SD, Terrault NA. Treatment of chronic hepatitis B. Curr Hepatitis Rep. 2003;2:49–59
- . Chen HL, Chang MH, Ni YH, . Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA. 1996;276(11):906–908
- . Wasley A, Kruszon-Moran D, Kuhnert W, . The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202(2):192–201
- . Chang TT, Lai CL, Kew Yoon S, . Entecavir treatment for up to 5 years in patients with hepatitis Be antigen-positive chronic hepatitis B. Hepatology. 2010;51(2):422–430
- . Heathcote EJ, Gane EJ, De Man RA, . Three years of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-positive patients with chronic hepatitis B (Study 103); preliminary analysis. AASLD 2009 Abstract 483. Hepatology. 2009;50:533A
- . Marcellin P, Buti M, Krastev Z., . Three years of tenofovir disoproxil fumarate (TDF) treatment in HBeAg-negative patients with chronic hepatitis B (Study 102); preliminary analysis. AASLD 2009 Abstract 481. Hepatology. 2009;50:532A
- . Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. 2006 Disease Profile, 2008:49–55
- . Centers for Disease Control and Prevention, Department of Health and Human Services. HIV/AIDS among Asians and Pacific Islanders 2008. http://www.cdc.gov/hiv/resources/factsheets/API.htm. Accessed August 2, 2010